Thompson Investment Management’s GSK GSK Stock Holding History

Thompson Investment Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$88.1K	Buy	1,680 +44	+3%	+$2.33K	0.01%	227
2026 Q1	$90.3K	Buy	1,636 +296	+22%	+$16K	0.01%	220
2025 Q4	$65.7K	Sell	1,340 -80	-6%	-$3.73K	0.01%	242
2025 Q3	$61.3K	Hold	1,420	–	–	0.01%	258
2025 Q2	$54.5K	Sell	1,420 -916	-39%	-$35K	0.01%	266
2025 Q1	$90.5K	Buy	2,336 +43	+2%	+$1.57K	0.01%	225
2024 Q4	$77.5K	Sell	2,293 -553	-19%	-$19.9K	0.01%	234
2024 Q3	$116K	Hold	2,846	–	–	0.02%	195
2024 Q2	$110K	Hold	2,846	–	–	0.02%	194
2024 Q1	$122K	Sell	2,846 -11	-0.4%	-$454	0.02%	191
2023 Q4	$106K	Hold	2,857	–	–	0.02%	202
2023 Q3	$104K	Buy	2,857 +100	+4%	+$3.55K	0.02%	202
2023 Q2	$98.3K	Buy	2,757 +115	+4%	+$4.13K	0.02%	210
2023 Q1	$94K	Buy	+2,642	New	+$92.4K	0.02%	212

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Thompson Investment Management's GSK Position: Q2 2026 in Review

Thompson Investment Management increased its GSK (GSK) stake by 2.7% in Q2 2026, buying an estimated $2.33K and bringing the position to 1,680 shares worth $88.1K. The position accounts for 0.01% of the portfolio, ranked #227.

Thompson Investment Management first reported a position in GSK in Q1 2023 and has held it in 14 quarters since. The position peaked at $122K in Q1 2024. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Thompson Investment Management held 1,680 shares of GSK worth $88.1K as of Q2 2026.
Thompson Investment Management bought 44 GSK shares in Q2 2026, an estimated $2.33K.
GSK made up 0.01% of Thompson Investment Management's portfolio in Q2 2026, its #227 holding.
Thompson Investment Management first reported a position in GSK in Q1 2023 and has held it in 14 quarters since.
Thompson Investment Management's GSK position peaked at $122K in Q1 2024.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Thompson Investment Management's 13F filing for Q2 2026, filed 13 Jul 2026.